JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NOVA
3801
DELISTED
Sunnova Energy
NOVA
| $2.61M | ﹤0.01% |
759,881
-271,660
| -26% | -$1.36M |
2019 Q3
21 quarters
|
|
3802
Zentalis Pharmaceuticals
ZNTL
$239M
| $2.6M | ﹤0.01% |
859,710
+370,511
| +76% | +$1.21M |
2020 Q2
18 quarters
|
|
3803
Pliant Therapeutics
PLRX
$63.8M
| $2.6M | ﹤0.01% |
197,251
+148,039
| +301% | +$2.02M |
2020 Q3
17 quarters
|
|
3804
Sierra Bancorp
BSRR
$515M
| $2.59M | ﹤0.01% |
89,616
+23,758
| +36% | +$711K |
2013 Q2
46 quarters
|
|
3805
Morgan Stanley Direct Lending Fund
MSDL
$1.14B
| $2.59M | ﹤0.01% |
125,416
+96,544
| +334% | +$1.97M |
2024 Q2
2 quarters
|
|
3806
Green Plains
GPRE
$1.07B
| $2.59M | ﹤0.01% |
272,845
+149,105
| +120% | +$1.68M |
2013 Q2
46 quarters
|
|
3807
Clean Energy Fuels
CLNE
$344M
| $2.58M | ﹤0.01% |
1,029,482
+299,264
| +41% | +$849K |
2017 Q1
31 quarters
|
|
3808
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $2.58M | ﹤0.01% |
15,537
-408
| -3% | -$69.7K |
2013 Q2
46 quarters
|
|
3809
Capital Group US Multi-Sector Income ETF
CGMS
$5.31B
| $2.58M | ﹤0.01% |
94,497
+5,802
| +7% | +$160K |
2023 Q4
4 quarters
|
|
3810
BrightView Holdings
BV
$952M
| $2.58M | ﹤0.01% |
161,056
+116,758
| +264% | +$1.94M |
2018 Q2
26 quarters
|
|
3811
iShares Core 5-10 Year USD Bond ETF
IMTB
$264M
| $2.58M | ﹤0.01% |
60,668
+38,954
| +179% | +$1.68M |
2021 Q3
13 quarters
|
|
3812
Pan American Silver
PAAS
$18.9B
| $2.57M | ﹤0.01% |
144,274
-55,917
| -28% | -$1.25M |
2014 Q1
43 quarters
|
|
3813
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.74B
| $2.57M | ﹤0.01% |
61,707
+6,788
| +12% | +$291K |
2022 Q2
10 quarters
|
|
3814
CALL
Li Auto
LI
$10.4B
| $2.57M | ﹤0.01% |
107,000
| – | – |
2023 Q3
5 quarters
|
|
|
HONE
3815
DELISTED
HarborOne Bancorp
HONE
| $2.57M | ﹤0.01% |
216,837
+95,659
| +79% | +$1.21M |
2017 Q4
28 quarters
|
|
3816
Martin Midstream Partners
MMLP
$85.3M
| $2.56M | ﹤0.01% |
713,930
+140,196
| +24% | +$555K |
2021 Q1
15 quarters
|
|
3817
Liberty Global Class A
LBTYA
$3.04B
| $2.56M | ﹤0.01% |
200,770
-410,610
| -67% | -$6.85M |
2013 Q2
46 quarters
|
|
3818
CALL
Cognizant
CTSH
$26.4B
| $2.56M | ﹤0.01% |
33,300
| – | – |
2024 Q1
3 quarters
|
|
3819
Clearwater Paper
CLW
$319M
| $2.56M | ﹤0.01% |
85,950
+46,611
| +118% | +$1.26M |
2015 Q4
36 quarters
|
|
3820
iRadimed
IRMD
$1.09B
| $2.56M | ﹤0.01% |
46,483
+17,257
| +59% | +$908K |
2016 Q3
33 quarters
|
|
3821
Republic Bancorp
RBCAA
$1.84B
| $2.55M | ﹤0.01% |
36,567
+19,932
| +120% | +$1.42M |
2013 Q2
46 quarters
|
|
3822
Cracker Barrel
CBRL
$1.25B
| $2.55M | ﹤0.01% |
48,167
+17,368
| +56% | +$859K |
2013 Q2
46 quarters
|
|
3823
iShares US Healthcare Providers ETF
IHF
$1.36B
| $2.55M | ﹤0.01% |
53,036
-10,390
| -16% | -$548K |
2013 Q2
46 quarters
|
|
3824
Fidelity Quality Factor ETF
FQAL
$1.43B
| $2.54M | ﹤0.01% |
38,752
+4,873
| +14% | +$324K |
2022 Q4
8 quarters
|
|
3825
Mid Penn Bancorp
MPB
$922M
| $2.53M | ﹤0.01% |
87,809
+25,267
| +40% | +$781K |
2018 Q2
26 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.